Fibrinolysis for acute myocardial infarction: the future is here and now.
Armstrong
Paul W
PW
Department of Medicine, 2-51 Medical Sciences Building, University of Alberta, Edmonton, Alberta, Canada T6G 2H7. paul.Armstrong@ualberta.ca
Collen
Désiré
D
Antman
Elliott
E
D000925:Anticoagulants / Q000627:therapeutic use; D000991:Antithrombins / Q000627:therapeutic use; D002986:Clinical Trials as Topic / Q000706:statistics & numerical data; D005342:Fibrinolysis; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006801:Humans; D009203:Myocardial Infarction / Q000188:drug therapy*; D015425:Myocardial Reperfusion / Q000379:methods; D055502:Secondary Prevention; D016896:Treatment Outcome
D000925:Anticoagulants; D000991:Antithrombins; D005343:Fibrinolytic Agents